Literature DB >> 35063885

Utility of a 7- question online screener for DHA intake.

D N Christifano1, S A Crawford2, G Lee3, B J Gajewski4, S E Carlson5.   

Abstract

The secondary analyses of two large, recently completed randomized clinical trials of DHA supplementation in pregnancy found that women with a low baseline DHA status benefited from randomization to a higher dose (800 vs 0 and 1000 vs 200 mg/day DHA). To obtain DHA status, it is necessary to obtain a blood sample and conduct an analysis using gas chromatography (GC) or GC-mass spectrometry (GCMS), both barriers to clinics where pregnant women receive advice on nutrition. Participants consuming less than 150 mg/day of DHA at baseline in our recent trial had a lower risk of early preterm birth and preterm birth when assigned to 1000 vs 200 m/day DHA. DHA intake was determined using a 7-question food frequency questionnaire administered by a trained nutritionist. Because the need for trained personnel to administer the questionnaire would be a barrier to implementing this finding in clinical management of pregnancy, the goal of this study was to determine if an online version of the questionnaire could be validly completed without assistance.
Copyright © 2022. Published by Elsevier Ltd.

Entities:  

Keywords:  DHA intake; Pregnancy; Preterm birth

Mesh:

Substances:

Year:  2022        PMID: 35063885      PMCID: PMC8825685          DOI: 10.1016/j.plefa.2022.102399

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  8 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Omega-3 fatty acid supplementation in pregnancy-baseline omega-3 status and early preterm birth: exploratory analysis of a randomised controlled trial.

Authors:  L A Simmonds; T R Sullivan; M Skubisz; P F Middleton; K P Best; L N Yelland; J Quinlivan; S J Zhou; G Liu; A J McPhee; R A Gibson; M Makrides
Journal:  BJOG       Date:  2020-03-03       Impact factor: 6.531

4.  The REDCap consortium: Building an international community of software platform partners.

Authors:  Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda
Journal:  J Biomed Inform       Date:  2019-05-09       Impact factor: 6.317

5.  Prenatal docosahexaenoic acid effect on maternal-infant DHA-equilibrium and fetal neurodevelopment: a randomized clinical trial.

Authors:  Kathleen M Gustafson; Danielle N Christifano; Dirk Hoyer; Alexander Schmidt; Susan E Carlson; John Colombo; Nicole B Mathis; Scott A Sands; Lynn Chollet-Hinton; Alexandra R Brown; Dinesh Pal Mudaranthakam; Byron J Gajewski
Journal:  Pediatr Res       Date:  2021-09-22       Impact factor: 3.953

6.  Food-frequency questionnaire for assessing long-chain ω-3 fatty-acid intake: Re: Assessing long-chain ω-3 polyunsaturated fatty acids: a tailored food-frequency questionnaire is better.

Authors:  Connye Kuratko
Journal:  Nutrition       Date:  2013-05       Impact factor: 4.008

7.  Validation of an abbreviated food frequency questionnaire for estimating DHA intake of pregnant women in the United States.

Authors:  S A Crawford; D N Christifano; E H Kerling; B J Gajewski; C J Valentine; K M Gustafson; N B Mathis; J T Camargo; H D Gibbs; D K Sullivan; S A Sands; S E Carlson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2022-01-13       Impact factor: 4.006

8.  Higher dose docosahexaenoic acid supplementation during pregnancy and early preterm birth: A randomised, double-blind, adaptive-design superiority trial.

Authors:  Susan E Carlson; Byron J Gajewski; Christina J Valentine; Elizabeth H Kerling; Carl P Weiner; Michael Cackovic; Catalin S Buhimschi; Lynette K Rogers; Scott A Sands; Alexandra R Brown; Dinesh Pal Mudaranthakam; Sarah A Crawford; Emily A DeFranco
Journal:  EClinicalMedicine       Date:  2021-05-17
  8 in total
  1 in total

1.  Maternal Docosahexaenoic Acid Exposure Needed to Achieve Maternal-Newborn EQ.

Authors:  Danielle N Christifano; Kathleen M Gustafson; Susan E Carlson; Nasrin Sultanna; Alexandra Brown; Scott A Sands; John Colombo; Byron J Gajewski
Journal:  Nutrients       Date:  2022-08-12       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.